Infliximab, residual rate and antibodies, serum


Reference Range

Infliximab (Remicade(R)) is a part human part murine chimeric antibody for antigen fixation. Its target is TNF alpha. It is used in the treatment of Chrons Disease and Rheumatoid poly arthritis and can induce the patient to synthesise neutralising antibodies. For patients not responding to Remicade it is then useful to test for anti Remicade antibodies.

Special Requirements

1 mL Serum Refrigerated Always draw blood at the same time before another administration Freeze the sample within 1 hour after sampling Please attach the specific clinical information sheet (R46 : Anti-TNF)

Ready within 21

Copyright © biolab 2024, Developed by Tech Factory

Hit enter to search or ESC to close